Triumph Capital Management Ishares Biotechnology ETF Transaction History
Triumph Capital Management
- $234 Million
- Q1 2024
A detailed history of Triumph Capital Management transactions in Ishares Biotechnology ETF stock. As of the latest transaction made, Triumph Capital Management holds 3,779 shares of IBB stock, worth $562,504. This represents 0.22% of its overall portfolio holdings.
Number of Shares
3,779
Previous 3,863
2.17%
Holding current value
$562,504
Previous $524,000
1.15%
% of portfolio
0.22%
Previous 0.23%
Shares
9 transactions
Others Institutions Holding IBB
# of Institutions
1,012Shares Held
35.9MCall Options Held
2.39MPut Options Held
10.2M-
Bank Of America Corp Charlotte, NC7.52MShares$1.12 Billion0.09% of portfolio
-
Goldman Sachs Group Inc New York, NY3.15MShares$469 Million0.07% of portfolio
-
Morgan Stanley New York, NY2.72MShares$405 Million0.03% of portfolio
-
Citigroup Inc1.98MShares$295 Million0.17% of portfolio
-
Royal Bank Of Canada Toronto, A61.28MShares$190 Million0.04% of portfolio